Environmental, Social And Governance Report

Overview

The report describes Luye Pharma's 2024 ESG governance, including a Board-established ESG Committee and annual review of ESG performance. It presents a five-step stakeholder materiality assessment, reports 1,392,264.00 Cubic meters of total water consumption, and records 5,150 employees. The report also records zero employee and contractor deaths and highlights R&D, medicine accessibility, and patient-assistance activities.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2024
Period: 1 January 2024 – 31 December 2024
Publication date: 27 March 2025
Language: English
Pages
File size
Restatement: Disclosed

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Ratings

GRI level

Materiality

Assessment
Basis
Matrix

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services